In the differential diagnosis of ovarian cancer and endometriosis, the ROMA algorithm and the HE4 marker performed better than CA125 (sensitivity 99 and 98.1%, versus 75.0%, respectively) [55]. This evidence concerns the gene MUC16 and ovarian carcinoma.